C101H106F10N22O4S4 — CID 161147383
1-cyclopropyl-2-[4-[4-(3-cyclopropyl-3-fluoroazetidin-1-yl)-6-[(3-methyl-2H-pyrrol-5-yl)amino]pyrimidin-2-yl]sulfanylphenyl]ethanone;1-[4-[4-(3-cyclopropyl-3-fluoroazetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-4,4,4-trifluorobutan-2-one;2-[4-[4-(3-cyclopropyl-3-fluoroazetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-1-[1-(trifluoromethyl)cyclopropyl]ethanone;1-[4-[4-(3-cyclopropyl-3-fluoroazetidin-1-yl)-6-[(3-methyl-2H-pyrrol-5-yl)amino]pyrimidin-2-yl]sulfanylphenyl]butan-2-one (PubChem CID 161147383) has the molecular formula C101H106F10N22O4S4 and a molecular weight of 2010.36 g/mol. Its IUPAC name is 1-cyclopropyl-2-[4-[4-(3-cyclopropyl-3-fluoroazetidin-1-yl)-6-[(3-methyl-2H-pyrrol-5-yl)amino]pyrimidin-2-yl]sulfanylphenyl]ethanone;1-[4-[4-(3-cyclopropyl-3-fluoroazetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-4,4,4-trifluorobutan-2-one;2-[4-[4-(3-cyclopropyl-3-fluoroazetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-1-[1-(trifluoromethyl)cyclopropyl]ethanone;1-[4-[4-(3-cyclopropyl-3-fluoroazetidin-1-yl)-6-[(3-methyl-2H-pyrrol-5-yl)amino]pyrimidin-2-yl]sulfanylphenyl]butan-2-one.
| Compound Name | 1-cyclopropyl-2-[4-[4-(3-cyclopropyl-3-fluoroazetidin-1-yl)-6-[(3-methyl-2H-pyrrol-5-yl)amino]pyrimidin-2-yl]sulfanylphenyl]ethanone;1-[4-[4-(3-cyclopropyl-3-fluoroazetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-4,4,4-trifluorobutan-2-one;2-[4-[4-(3-cyclopropyl-3-fluoroazetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-1-[1-(trifluoromethyl)cyclopropyl]ethanone;1-[4-[4-(3-cyclopropyl-3-fluoroazetidin-1-yl)-6-[(3-methyl-2H-pyrrol-5-yl)amino]pyrimidin-2-yl]sulfanylphenyl]butan-2-one |
|---|---|
| PubChem CID | 161147383 |
| Molecular Formula | C101H106F10N22O4S4 |
| Molecular Weight | 2010.36 g/mol |
| Exact Mass | 2008.75 |
| IUPAC Name | 1-cyclopropyl-2-[4-[4-(3-cyclopropyl-3-fluoroazetidin-1-yl)-6-[(3-methyl-2H-pyrrol-5-yl)amino]pyrimidin-2-yl]sulfanylphenyl]ethanone;1-[4-[4-(3-cyclopropyl-3-fluoroazetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-4,4,4-trifluorobutan-2-one;2-[4-[4-(3-cyclopropyl-3-fluoroazetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]-1-[1-(trifluoromethyl)cyclopropyl]ethanone;1-[4-[4-(3-cyclopropyl-3-fluoroazetidin-1-yl)-6-[(3-methyl-2H-pyrrol-5-yl)amino]pyrimidin-2-yl]sulfanylphenyl]butan-2-one |
| SMILES | CC1=CC(Nc2cc(N3CC(F)(C4CC4)C3)nc(Sc3ccc(CC(=O)C4CC4)cc3)n2)=NC1.CCC(=O)Cc1ccc(Sc2nc(NC3=NCC(C)=C3)cc(N3CC(F)(C4CC4)C3)n2)cc1.Cc1cc(Nc2cc(N3CC(F)(C4CC4)C3)nc(Sc3ccc(CC(=O)C4(C(F)(F)F)CC4)cc3)n2)n[nH]1.Cc1cc(Nc2cc(N3CC(F)(C4CC4)C3)nc(Sc3ccc(CC(=O)CC(F)(F)F)cc3)n2)n[nH]1 |
| InChI | InChI=1S/C26H26F4N6OS.C26H28FN5OS.C25H28FN5OS.C24H24F4N6OS/c1-15-10-21(35-34-15)31-20-12-22(36-13-25(27,14-36)17-4-5-17)33-23(32-20)38-18-6-2-16(3-7-18)11-19(37)24(8-9-24)26(28,29)30;1-16-10-22(28-13-16)29-23-12-24(32-14-26(27,15-32)19-6-7-19)31-25(30-23)34-20-8-2-17(3-9-20)11-21(33)18-4-5-18;1-3-19(32)11-17-4-8-20(9-5-17)33-24-29-22(28-21-10-16(2)13-27-21)12-23(30-24)31-14-25(26,15-31)18-6-7-18;1-14-8-20(33-32-14)29-19-10-21(34-12-23(25,13-34)16-4-5-16)31-22(30-19)36-18-6-2-15(3-7-18)9-17(35)11-24(26,27)28/h2-3,6-7,10,12,17H,4-5,8-9,11,13-14H2,1H3,(H2,31,32,33,34,35);2-3,8-10,12,18-19H,4-7,11,13-15H2,1H3,(H,28,29,30,31);4-5,8-10,12,18H,3,6-7,11,13-15H2,1-2H3,(H,27,28,29,30);2-3,6-8,10,16H,4-5,9,11-13H2,1H3,(H2,29,30,31,32,33) |
| InChIKey | UOFSXLDBMPCKHL-UHFFFAOYSA-N |
| XLogP | 20.92 |
| TPSA | 314.56 Ų |
| H-Bond Donors | 6 |
| H-Bond Acceptors | 28 |
| Rotatable Bonds | 34 |
| Heavy Atoms | 141 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2010.36 |
| LogP ≤ 5 | 20.92 |
| H-Bond Donors ≤ 5 | 6 |
| H-Bond Acceptors ≤ 10 | 28 |